THOMPSON KIMBERLY KRAIG (CEO, CFO) sold 0.0% of their position (40.05K shares) of KRAIG BIOCRAFT LABORATORIES, INC. on the open market
Insider sale on the open market — a minor trim. Check remaining position size for full context.
S · 2 sales
Filed: 5/23/2022ACC: 0001493152-22-014805
DirectorOfficer10% Owner· CEO, CFO
Since Dec 2020
-40.05K
Net shares
Net seller
$0.00
Total acquired
2
Open market trades
0B · 2S
2
Total transactions
40.05K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−15.05K
Price / share
—
Trade value
—
% of position
0.0%
5/19/2022
202.88M→202.87M
Common Stock
Direct
Shares
−25K
Price / share
—
Trade value
—
% of position
0.0%
5/20/2022
202.87M→202.84M
Total
Net shares
−40.05K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/19/2022 | S · Sale | −15.05K | — | — | 0.0% | 202.88M | 202.87M |
| Common Stock Direct | 5/20/2022 | S · Sale | −25K | — | — | 0.0% | 202.87M | 202.84M |
| Total | −40.05K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported